School of Medicine
Showing 151-160 of 4,789 Results
-
Themistocles (Tim) Assimes
Associate Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsGenetic Epidemiology, Genetic Determinants of Complex Traits related to Cardiovasular Medicine, Coronary Artery Disease related pathway analyses and integrative genomics, Mendelian randomization studies, risk prediction for major adverse cardiovascular events, cardiovascular medicine related pharmacogenomics, ethnic differences in the determinants of Insulin Mediated Glucose Uptake, pharmacoepidemiology of cardiovascular drugs & outcomes
-
Diana Atashroo
Clinical Associate Professor, Obstetrics & Gynecology
BioDr. Diana Atashroo is coming to Stanford Hospital from NorthShore UniversityHealthSysteml in Illinois, affiliated with the the University of Chicago-Pritzker School of Medicine.
Dr. Atashroo sees patients for general gynecology and a variety of other complex gynecologic issues. Her expertise includes evaluation and management of complex pelvic pathology and pelvic pain. Her special interests include: pudendal neuralgia and other peripheral neuropathic pain conditions, pelvic floor muscle spasms, vulvodynia, pelvic congestion syndrome, endometriosis, and interstitial cystitis. She also performs minimally-invasive gynecologic surgery, including laparoscopic and robotic procedures. She has special skills in ultrasound-guided peripheral nerve blocks, office procedures, and Botox trigger point injections.
She has leadership roles within AAGL (American Association of Gynecologic Laparoscopists) and IPPS (International Pelvic Pain Society) and has presented on various topics related to pelvic pain.
Dr. Atashroo is committed to furthering the well-being of women, and strives to provider her patients with an individualized and comprehensive approach. -
Laura Attardi
Catharine and Howard Avery Professor of the School of Medicine and Professor of Genetics
Current Research and Scholarly InterestsOur research is aimed at defining the pathways of p53-mediated apoptosis and tumor suppression, using a combination of biochemical, cell biological, and mouse genetic approaches. Our strategy is to start by generating hypotheses about p53 mechanisms of action using primary mouse embryo fibroblasts (MEFs), and then to test them using gene targeting technology in the mouse.
